Whole-Cell Biosynthesis of Branched Human Milk Hexasaccharide Lacto-N-neohexaose
- 2 July 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (28) , 17814-17823
Abstract
The inaccessibility of the enzyme responsible for β-1,6-GlcNAc branching has limited the production of branched human milk oligosaccharides (HMOs) using engineered strains. Herein, a recombinant Escherichia coli strain was metabolically engineered to serve as a whole-cell factory for the synthesis of lacto-N-neohexaose (LNnH), which represents the initial structure of branched HMOs, enabling access to diverse branched HMOs. Soluble expression of human β-1,6-N-acetylglucosaminyltransferase 2 (GCNT2) was achieved in E. coli SHuffle T7, providing a robust toolbox for the assembly of branched HMOs. Additionally, the genes encoding the LNnH biosynthesis pathway were well-designed, and the yield was increased from 1.04 to 21.19 mg/L. The production of LNnH was further increased to 173.21 mg/L in a 5 L bioreactor, representing a 166.5-fold increase over the starting engineered strain. This whole-cell biosynthetic strategy not only paves the way for accessing abundant branched HMOs but also enhances the field of HMO glycomics, opening new avenues for biological applications.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2103100)
- Key Technology Research and Development Program of Shandong Province (2022SFGC0103)
This publication has 31 references indexed in Scilit:
- A novel pH-stat fed-batch strategy to boost the production of nicotinamide mononucleotide by high cell density fermentationChemical Engineering Science, 2024
- Enzymatic modular synthesis of asymmetrically branched human milk oligosaccharidesCarbohydrate Polymers, 2024
- Biosynthesis of Lacto-N-fucopentaose I in Escherichia coli by metabolic pathway rational designCarbohydrate Polymers, 2022
- Glycosyltransferase from Bacteroides gallinaceum Is a Novel α-1,3-Fucosyltransferase that Can Be Used for 3-Fucosyllactose Production In Vivo by Metabolically Engineered Escherichia coliJournal of Agricultural and Food Chemistry, 2022
- Metabolic Engineering of Escherichia coli for Lacto-N-triose II Production with High ProductivityJournal of Agricultural and Food Chemistry, 2021
- Human milk oligosaccharides: Shaping the infant gut microbiota and supporting healthJournal of Functional Foods, 2020
- Donor substrate promiscuity of bacterial β1–3-N-acetylglucosaminyltransferases and acceptor substrate flexibility of β1–4-galactosyltransferasesBioorganic & Medicinal Chemistry, 2016
- Human Milk Oligosaccharides (HMOS)2015
- LacZ β‐galactosidase: Structure and function of an enzyme of historical and molecular biological importanceProtein Science, 2012
- High cell density fed-batch cultivation of Escherichia coli using exponential feeding combined with pH-statBioprocess and Biosystems Engineering, 2004